DuPont Finalizes Aramids Business Sale to Arclin, Sets April 1st Closing
Summary
DuPont announced the satisfaction of all regulatory conditions for the sale of its Aramids business to Arclin, with the closing expected on April 1, 2026.
Key Events
-
Aramids Business Sale Finalized
DuPont expects to close the previously announced sale of its Aramids business (Kevlar® and Nomex®) to Arclin on April 1, 2026.
-
Regulatory Conditions Met
All regulatory conditions required to close the sale transaction were satisfied as of March 10, 2026, removing a key hurdle for the divestiture.
Analysis
This filing provides a crucial update on DuPont's previously announced strategic divestiture of its Aramids business (Kevlar® and Nomex®). The confirmation that all regulatory conditions have been satisfied and a definitive closing date of April 1, 2026, has been set removes significant uncertainty surrounding this major portfolio change. This finalization is a positive step in the company's strategic repositioning, following the large impairment charges related to this divestiture reported in the recent 10-K.
At the time of this filing, DD was trading at $45.40 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $18.6B. The 52-week trading range was $22.49 to $52.66. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.